Home › Psoriatic Arthritis › District of Columbia
Psoriatic Arthritis clinical trials in District of Columbia
3 studies for Psoriatic Arthritis are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT03816345A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Childrens National Medical Center /ID# 259284, Washington D.C.
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Childrens National Medical Center, Washington D.C.
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.